학술논문

Updated Interim Analysis from Keynote-057: Pembrolizumab Monotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)
Document Type
Journal
Source
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY; JUL 2019, 15 p52-p53, 2p. Supplement: 4
Subject
Language
English
ISSN
17437563